X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15017) 15017
Book Review (3802) 3802
Publication (1490) 1490
Newspaper Article (1470) 1470
Newsletter (530) 530
Trade Publication Article (142) 142
Book Chapter (135) 135
Magazine Article (119) 119
Conference Proceeding (52) 52
Government Document (37) 37
Dissertation (25) 25
Book / eBook (17) 17
Web Resource (11) 11
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11418) 11418
prostate cancer (11117) 11117
humans (10535) 10535
male (10357) 10357
androgens (6054) 6054
oncology (5855) 5855
cancer (4226) 4226
aged (3878) 3878
prostatic neoplasms - drug therapy (3785) 3785
urology & nephrology (3772) 3772
prostatic neoplasms - pathology (3594) 3594
middle aged (3284) 3284
care and treatment (3207) 3207
androgen antagonists - therapeutic use (2992) 2992
research (2674) 2674
metastasis (2569) 2569
androgen deprivation therapy (2313) 2313
prostate (2257) 2257
animals (2203) 2203
androgen receptor (2198) 2198
radiotherapy (2072) 2072
men (2054) 2054
radical prostatectomy (1992) 1992
health aspects (1899) 1899
testosterone (1861) 1861
aged, 80 and over (1744) 1744
cancer therapies (1713) 1713
prostatic neoplasms - metabolism (1710) 1710
treatment outcome (1705) 1705
prostatic neoplasms - therapy (1696) 1696
androgen-deprivation therapy (1687) 1687
carcinoma (1609) 1609
risk factors (1577) 1577
analysis (1538) 1538
urology (1469) 1469
prostatic neoplasms - radiotherapy (1460) 1460
endocrinology & metabolism (1455) 1455
prostate-specific antigen - blood (1455) 1455
cell line, tumor (1431) 1431
therapy (1381) 1381
receptors, androgen - metabolism (1352) 1352
chemotherapy (1309) 1309
expression (1277) 1277
androgen deprivation (1256) 1256
survival (1249) 1249
castration (1232) 1232
antineoplastic agents, hormonal - therapeutic use (1225) 1225
prostatic neoplasms - genetics (1217) 1217
prognosis (1150) 1150
development and progression (1103) 1103
prostatic neoplasms - mortality (1099) 1099
radiation-therapy (1088) 1088
abridged index medicus (1086) 1086
progression (1068) 1068
article (1049) 1049
patients (1046) 1046
mice (1045) 1045
tumors (1043) 1043
prostatic neoplasms - blood (1041) 1041
oncology, experimental (1020) 1020
prostatic neoplasms - surgery (1011) 1011
disease progression (1003) 1003
androgen antagonists - adverse effects (980) 980
prostatectomy (948) 948
quality of life (933) 933
risk (929) 929
orchiectomy (923) 923
apoptosis (902) 902
neoplasm staging (900) 900
radiation therapy (889) 889
clinical trials (888) 888
retrospective studies (882) 882
adult (881) 881
female (877) 877
receptors, androgen - genetics (874) 874
gene expression (870) 870
quality-of-life (857) 857
radiology, nuclear medicine & medical imaging (853) 853
mortality (848) 848
hormones (832) 832
prostate-specific antigen (811) 811
cell biology (805) 805
hematology, oncology and palliative medicine (801) 801
medicine & public health (797) 797
prostate-cancer (746) 746
combined modality therapy (739) 739
follow-up studies (739) 739
time factors (736) 736
disease-free survival (732) 732
randomized controlled-trial (732) 732
medical research (710) 710
prostatic neoplasms (707) 707
physiological aspects (697) 697
biochemistry & molecular biology (686) 686
studies (685) 685
androgens - metabolism (679) 679
metastases (679) 679
antigens (675) 675
genetic aspects (675) 675
proteins (675) 675
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16805) 16805
German (211) 211
French (205) 205
Spanish (104) 104
Japanese (49) 49
Chinese (17) 17
Russian (11) 11
Czech (5) 5
Italian (5) 5
Portuguese (5) 5
Dutch (4) 4
Korean (4) 4
Polish (4) 4
Croatian (3) 3
Turkish (3) 3
Hungarian (2) 2
Serbian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Belarusian (1) 1
Danish (1) 1
Slovak (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 8, pp. 745 - 755
Men receiving androgen-deprivation therapy for nonmetastatic prostate cancer are at high risk for bone loss and fractures. This placebo-controlled study... 
ZOLEDRONIC ACID | MEDICINE, GENERAL & INTERNAL | PLACEBO | BONE-MINERAL DENSITY | FRACTURES | RISK | COMPLICATIONS | RANDOMIZED CONTROLLED-TRIAL | POSTMENOPAUSAL WOMEN | OSTEOPOROSIS | ALENDRONATE | Lumbar Vertebrae - injuries | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Fractures, Bone - epidemiology | Antibodies, Monoclonal - therapeutic use | Male | Osteoporosis - drug therapy | Prostatic Neoplasms - physiopathology | Bone Remodeling - drug effects | Incidence | Antibodies, Monoclonal, Humanized | Spinal Fractures - prevention & control | RANK Ligand - pharmacology | Injections, Subcutaneous | Aged, 80 and over | RANK Ligand - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Lumbar Vertebrae - physiology | Prostatic Neoplasms - drug therapy | RANK Ligand - adverse effects | Osteoporosis - chemically induced | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Prostatic Neoplasms - surgery | Antibodies, Monoclonal - pharmacology | Spinal Fractures - epidemiology | Bone Density Conservation Agents - therapeutic use | Lumbar Vertebrae - drug effects | Denosumab | Bone Density Conservation Agents - pharmacology | Orchiectomy | Bone Density - drug effects | Androgen Antagonists - therapeutic use | Aged | Androgen Antagonists - adverse effects | Fractures, Bone - prevention & control | Osteoporosis | Bone density | Prostate cancer | Older people | Men | Index Medicus | Abridged Index Medicus
Journal Article
Oncotarget, ISSN 1949-2553, 2014, Volume 5, Issue 24, pp. 12665 - 12674
Although accumulating preclinical evidence indicates the involvement of androgen receptor signals in bladder cancer (BC) development, its clinical relevance... 
Recurrence | Androgen deprivation therapy | Androgen | Bladder cancer | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9809, pp. 2104 - 2111
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 787 - 794
Journal Article
Journal Article
AGING-US, ISSN 1945-4589, 08/2019, Volume 11, Issue 15, pp. 5613 - 5627
Background: Prostate cancer (PC) is the most frequent neoplasia in the male population and androgen deprivation therapy (ADT) is frequently used in the... 
androgen deprivation therapy | TESTOSTERONE TREATMENT | COGNITIVE RESERVE | DEMENTIA | EDUCATION | DECLINE | CELL BIOLOGY | GERIATRICS & GERONTOLOGY | prostate cancer | grey matter volume | white matter lesion | PREDICTORS | PROSTATE-CANCER | MEN | cognitive impairment | MATTER HYPERINTENSITY VOLUME | PROGRESSION | Index Medicus
Journal Article
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. e567 - e567
Journal Article